| Product Code: ETC9918405 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Cannabis Pharmaceutical Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Cannabis Pharmaceutical Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume Share, By Compound Type, 2021 & 2031F |
3.8 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance of medical cannabis for various health conditions |
4.2.2 Growing awareness about the potential benefits of cannabis-based pharmaceutical products |
4.2.3 Favorable government regulations and policies supporting the cannabis pharmaceutical market in UAE |
4.3 Market Restraints |
4.3.1 Cultural and societal stigmas associated with cannabis use in the UAE |
4.3.2 Limited research and clinical trials on cannabis pharmaceutical products |
4.3.3 Supply chain challenges and logistics issues related to importing and distributing cannabis products in the UAE |
5 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Trends |
6 United Arab Emirates (UAE) Cannabis Pharmaceutical Market, By Types |
6.1 United Arab Emirates (UAE) Cannabis Pharmaceutical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Capsules, 2021- 2031F |
6.1.4 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Concentrates, 2021- 2031F |
6.1.5 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Edibles, 2021- 2031F |
6.2 United Arab Emirates (UAE) Cannabis Pharmaceutical Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Epidiolex, 2021- 2031F |
6.2.3 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Marinol, 2021- 2031F |
6.2.4 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Cesamet, 2021- 2031F |
6.2.5 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Sativex, 2021- 2031F |
6.3 United Arab Emirates (UAE) Cannabis Pharmaceutical Market, By Compound Type |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Tetrahydrocannabinol (THC), 2021- 2031F |
6.3.3 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Cannabidiol (CBD), 2021- 2031F |
6.3.4 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Balanced THC & CBD, 2021- 2031F |
6.4 United Arab Emirates (UAE) Cannabis Pharmaceutical Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Inflammation, 2021- 2031F |
6.4.3 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Chronic Pain, 2021- 2031F |
6.4.4 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.4.5 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Sleep Disorders, 2021- 2031F |
6.4.6 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Anorexia, 2021- 2031F |
6.4.7 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.5 United Arab Emirates (UAE) Cannabis Pharmaceutical Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6 United Arab Emirates (UAE) Cannabis Pharmaceutical Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Imports from Major Countries |
8 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Key Performance Indicators |
8.1 Number of licensed cannabis pharmaceutical companies operating in the UAE |
8.2 Percentage of healthcare professionals educated on the use of cannabis-based medicines |
8.3 Research and development investment in cannabis pharmaceutical products in the UAE |
9 United Arab Emirates (UAE) Cannabis Pharmaceutical Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Opportunity Assessment, By Compound Type, 2021 & 2031F |
9.4 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Arab Emirates (UAE) Cannabis Pharmaceutical Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Cannabis Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here